Spectra Systems Corporation
("Spectra" or the "Company")
Exercise of Options and Director/PDMR Shareholding
Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies and gaming security software, announces the exercise of options by both Brian McLain, Chief Financial Officer of Spectra and an employee.
Mr. McLain has exercised options over 212,000 shares of common stock of $0.01 each in the Company ("Shares"), with an exercise price of $0.49 per share. Mr. McLain has elected to utilize the net cashless exercise feature and has surrendered 56,762 shares to the Company at the prevailing market price of $1.83. Accordingly Mr. McLain will be issued a net total of 155,238 shares, increasing his interest in the issued share capital of the Company to 193,238 shares, representing 0.42% of its issued share capital.
In addition, an employee has exercised options over 19,000 shares of common stock of $0.01 each in the Company ("Shares"), with an exercise price of 25p per share. The Company has received US$5,924.17 in respect of this exercise of options.
The shares being issued are restricted securities as defined in Rule 144 of the US Securities Act of 1933 and have been issued pursuant to an exemption from registration under Rule 701 promulgated under the US Securities Act of 1933.
Accordingly the Company has issued and will apply for 174,238 Shares to be admitted to trading on AIM, which is expected to take place on or around 31 May 2022 ("Admission").
Following Admission the Company's issued share capital will comprise:
·1,148,830 shares in the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC); and
·44,345,847 shares in the unrestricted line ISIN number US84756T1060 (AIM:SPSY).
In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA ("DTRs"), the issued share capital of Spectra upon Admission is 45,494,677 shares with voting rights attached (one vote per share). There are no shares held in treasury, therefore this figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify
Enquiries:
| Spectra Systems Corporation Dr. Nabil Lawandy, Chief Executive Officer
| Tel: +1 (0)401 274 4700
|
| WH Ireland Limited (Nominated Adviser and Broker) Chris Fielding (Head of Corporate Finance) Andrew de Andrade (Executive, Corporate Finance)
Allenby Capital Limited (Joint Broker) Nick Naylor/James Reeve (Corporate Finance) Amrit Nahal (Sales and Corporate Broking) | Tel: +44 (0)20 7220 1650
Tel: +44 (0)20 3328 5665
|
The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Brian McLain | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Chief Financial Officer | ||||
| b) | Initial notification/ Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Spectra Systems Corporation | ||||
| b) | LEI | 21380047EWJYQG53D640 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument
Identification code | Regulation S restricted common stock of US$0.01
USU8457D1091 | ||||
| b) | Nature of the transaction | Exercise of Options | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price |
155,238 common shares $0.49 USD | ||||
| e) | Date of the transaction | 24 May 2022 | ||||
| f) | Place of the transaction | London Stock Exchange | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.